Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 8.42
+0.06 (0.72%)
Sep 29, 2025, 4:08 PM HKT
HKG:0512 Market Cap
HKG:0512 has a market cap or net worth of 29.28 billion as of September 29, 2025. Its market cap has increased by 89.14% in one year.
Market Cap
29.28B
Enterprise Value
31.69B
Revenue
11.70B
Ranking
n/a
PE Ratio
14.07
Stock Price
8.42
Market Cap Chart
Since February 28, 1996, HKG:0512's market cap has increased from 1.42B to 29.28B, an increase of 1,955.88%. That is a compound annual growth rate of 10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 29.28B | 74.17% |
| Dec 31, 2024 | 16.81B | 16.78% |
| Dec 29, 2023 | 14.39B | -11.29% |
| Dec 30, 2022 | 16.22B | -29.24% |
| Dec 31, 2021 | 22.93B | -6.10% |
| Dec 31, 2020 | 24.42B | 70.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.56B |
| JD Health International | 215.78B |
| Hansoh Pharmaceutical Group Company | 215.28B |
| Innovent Biologics | 159.71B |
| WuXi Biologics | 158.73B |
| Sino Biopharmaceutical | 143.26B |
| Akeso | 125.00B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |